These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12753286

  • 1. Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency.
    Assink K, Schiphorst R, Allford S, Karpman D, Etzioni A, Brichard B, van de Kar N, Monnens L, van den Heuvel L.
    Kidney Int; 2003 Jun; 63(6):1995-9. PubMed ID: 12753286
    [Abstract] [Full Text] [Related]

  • 2. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH, van de Kar NC, van den Heuvel LP.
    Ned Tijdschr Geneeskd; 2003 Dec 06; 147(49):2422-4. PubMed ID: 14694551
    [Abstract] [Full Text] [Related]

  • 3. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
    Schneppenheim R, Budde U, Oyen F, Angerhaus D, Aumann V, Drewke E, Hassenpflug W, Häberle J, Kentouche K, Kohne E, Kurnik K, Mueller-Wiefel D, Obser T, Santer R, Sykora KW.
    Blood; 2003 Mar 01; 101(5):1845-50. PubMed ID: 12393505
    [Abstract] [Full Text] [Related]

  • 4. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C, Stapenhorst L, Simon T, Budde U, Schneppenheim R, Hoppe B.
    Kidney Int; 2004 Sep 01; 66(3):955-8. PubMed ID: 15327386
    [Abstract] [Full Text] [Related]

  • 5. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity.
    Savasan S, Lee SK, Ginsburg D, Tsai HM.
    Blood; 2003 Jun 01; 101(11):4449-51. PubMed ID: 12576319
    [Abstract] [Full Text] [Related]

  • 6. The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice.
    De Cock E, Hermans C, De Raeymaecker J, De Ceunynck K, De Maeyer B, Vandeputte N, Vandenbulcke A, Deckmyn H, Rottensteiner H, De Maeyer M, De Meyer SF, Vanhoorelbeke K.
    J Thromb Haemost; 2015 Feb 01; 13(2):283-92. PubMed ID: 25442981
    [Abstract] [Full Text] [Related]

  • 7. Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
    Veyradier A, Lavergne JM, Ribba AS, Obert B, Loirat C, Meyer D, Girma JP.
    J Thromb Haemost; 2004 Mar 01; 2(3):424-9. PubMed ID: 15009458
    [Abstract] [Full Text] [Related]

  • 8. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun 01; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 9. Congenital thrombotic thrombocytopenic purpura caused by new compound heterozygous mutations of the ADAMTS13 gene.
    Rank CU, Kremer Hovinga J, Taleghani MM, Lämmle B, Gøtze JP, Nielsen OJ.
    Eur J Haematol; 2014 Feb 01; 92(2):168-71. PubMed ID: 24033710
    [Abstract] [Full Text] [Related]

  • 10. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.
    Antoine G, Zimmermann K, Plaimauer B, Grillowitzer M, Studt JD, Lämmle B, Scheiflinger F.
    Br J Haematol; 2003 Mar 01; 120(5):821-4. PubMed ID: 12614216
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE, Moake JL, Miyata T, George JN.
    Hematology Am Soc Hematol Educ Program; 2004 Mar 01; ():407-23. PubMed ID: 15561695
    [Abstract] [Full Text] [Related]

  • 12. Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.
    Loirat C, Veyradier A, Girma JP, Ribba AS, Meyer D.
    Semin Thromb Hemost; 2006 Mar 01; 32(2):90-7. PubMed ID: 16575683
    [Abstract] [Full Text] [Related]

  • 13. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura.
    Snider CE, Moore JC, Warkentin TE, Finch CN, Hayward CP, Kelton JG.
    Am J Hematol; 2004 Dec 01; 77(4):387-90. PubMed ID: 15551280
    [Abstract] [Full Text] [Related]

  • 14. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.
    Peyvandi F, Ferrari S, Lavoretano S, Canciani MT, Mannucci PM.
    Br J Haematol; 2004 Nov 01; 127(4):433-9. PubMed ID: 15521921
    [Abstract] [Full Text] [Related]

  • 15. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B.
    N Engl J Med; 1998 Nov 26; 339(22):1578-84. PubMed ID: 9828245
    [Abstract] [Full Text] [Related]

  • 16. Low incidence of ADAMTS13 missense mutation R1060W in adult Egyptian patients with thrombotic thrombocytopenic purpura.
    El Sissy MH, El Hafez AA, El Sissy AH.
    Acta Haematol; 2014 Nov 26; 132(1):30-5. PubMed ID: 24401653
    [Abstract] [Full Text] [Related]

  • 17. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM.
    J Mol Med (Berl); 2002 Oct 26; 80(10):639-47. PubMed ID: 12395148
    [Abstract] [Full Text] [Related]

  • 18. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
    te Loo DM, Levtchenko E, Furlan M, Roosendaal GP, van den Heuvel LP.
    Pediatr Nephrol; 2000 Aug 26; 14(8-9):762-5. PubMed ID: 10955922
    [Abstract] [Full Text] [Related]

  • 19. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
    Kokame K, Miyata T.
    Semin Hematol; 2004 Jan 26; 41(1):34-40. PubMed ID: 14727257
    [Abstract] [Full Text] [Related]

  • 20. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W, Tsai HM.
    Thromb Haemost; 2004 Apr 26; 91(4):806-11. PubMed ID: 15045144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.